Login / Signup

P2x4 receptor promotes mammary cancer progression by sustaining autophagy and associated mesenchymal transition.

Stéphanie ChadetJordan AllardLucie BrissonOsbaldo Lopez-CharcasRoxane LemoineAudrey HeraudStéphanie LerondelRoseline GuibonGaëlle FromontAlain Le PapeDenis AngoulvantLin-Hua JiangRuth Murrell-LagnadoSébastien Roger
Published in: Oncogene (2022)
Metastatic progression is a major burden for breast cancer patients and is associated with the ability of cancer cells to overcome stressful conditions, such as nutrients deprivation and hypoxia, and to gain invasive properties. Autophagy and epithelial-to-mesenchymal transition are critical contributors to these processes. Here, we show that the P2X4 purinergic receptor is upregulated in breast cancer biopsies from patients and it is primarily localised in endolysosomes. We demonstrate that P2X4 enhanced invasion in vitro, as well as mammary tumour growth and metastasis in vivo. The pro-malignant role of P2X4 was mediated by the regulation of lysosome acidity, the promotion of autophagy and cell survival. Furthermore, the autophagic activity was associated with epithelial-to-mesenchymal transition (EMT), and this role of P2X4 was even more pronounced under metabolic challenges. Pharmacological and gene silencing of P2X4 inhibited both autophagy and EMT, whereas its rescue in knocked-down cells led to the restoration of the aggressive phenotype. Together, our results demonstrate a previously unappreciated role for P2X4 in regulating lysosomal functions and fate, promoting breast cancer progression and aggressiveness.
Keyphrases